Laboratorio Reig Jofre S.A. Logo

Laboratorio Reig Jofre S.A.

A pharmaceutical company making essential health products accessible in over 70 countries.

RJF | MC

Overview

Corporate Details

ISIN(s):
ES0165359029
LEI:
9598003MRMJHA81QJF20
Country:
Spain
Address:
Gran Capità 10, 08970 Sant Joan Despí
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Reig Jofre S.A., established in 1929, is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, food supplements, and nutritional cosmetics. The company operates four development and production centers in Europe, supporting its global distribution network which spans over 70 countries through subsidiaries and business partners. With a focus on technological specialization, Reig Jofre is dedicated to making essential health products accessible worldwide. The company employs over 1,100 people to support its international operations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 11:36
Notice of Dividend Amount
Reig Jofre informa sobre el inicio del Scrip Dividend
Spanish 168.7 KB
2025-05-09 07:59
Share Issue/Capital Change
Reig Jofre remite las condiciones y el informe del Scrip Dividend
Spanish 454.9 KB
2025-05-09 07:48
Board/Management Information
Reig Jofre informa del cambio de Secretario no Consejero del Consejo de Adminis…
Spanish 150.2 KB
2025-05-09 07:44
Quarterly Report
Reig Jofre remite nota de prensa sobre los resultados del primer trimestre de 2…
Spanish 528.9 KB
2025-05-09 07:43
Investor Presentation
Reig Jofre presenta los resultados del primer trimestre de 2025
Spanish 4.6 MB
2025-05-08 19:43
Capital/Financing Update
Reig Jofre remite nota de prensa sobre la subvención obtenida del CDTi para imp…
Spanish 476.0 KB
2025-04-09 18:17
Post-Annual General Meeting Information
Reig Jofre remite los acuerdos adoptados en la Junta General de Accionistas de …
Spanish 160.4 KB
2025-04-04 01:28
Transaction in Own Shares
Reig Jofre informa de las operaciones realizadas durante el primer trimestre de…
English 705.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 09:54
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
Convocatoria de la Junta General Ordinaria de Accionistas de 2025
Spanish 306.9 KB
2025-02-28 14:18
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 177.5 KB
2025-02-28 14:15
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 386.7 KB
2025-02-28 07:33
Earnings Release
Reig Jofre remite nota de prensa sobre los resultados de 2024
Spanish 867.1 KB
2025-02-28 07:31
Investor Presentation
Reig Jofre presenta los resultados de 2024
Spanish 1.9 MB

Automate Your Workflow. Get a real-time feed of all Laboratorio Reig Jofre S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Laboratorio Reig Jofre S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.